Zelestra has commenced construction of three PV plants—Belinchón I, II, and III—in Cuenca, Castilla-La Mancha, Spain, with a combined capacity of 162 MW (DC). These facilities, set to become operational by the second quarter of 2026, are expected to prevent the emission of over 71,000 tons of CO2 annually. The construction phase will generate more than 400 jobs, contributing to local economic development. These projects are part of the Energize program, a collaborative initiative involving Takeda Pharmaceuticals International AG, Teva Pharmaceutical Industries, UCB, Avantor, Organon LLC, Perrigo, and West Pharmaceutical Services Inc. As part of this program, Zelestra will supply an aggregated total of 305 GWh of renewable energy annually for a 10-year period.
Zelestra begins 162 MW solar plants in Spain
Scheduled for Q2 2026, the Belinchón I, II, and III solar plants will deliver 305 GWh of clean energy annually under the Energize program. (Image Source: Zelestra)
The Tenevo project will generate 300 GWh annually, reducing CO2 emissions by 250,000 tons each year. (Image Source: EBRD)
R3 Renewables aims to power 850,000 homes with solar and battery storage across the Midwest. (Image Source: RWE)
The INR1,080 crore infrastructure projects are enhancing Ladakh’s power supply under the Revamped Distribution Sector Scheme. (Image Credit/Source: Pixabay/Pexels)
Solar arrays on tracking racks to maximize output at Mink Solar’s 140 MW project in Ohio. (Image Credit/Source:Kelly/Pexels)